Study shows pills prevent HIV, as drug access increases
Daily pills can help to prevent the HIV/AIDS infection in heterosexual men and women, two new African studies have found.
The research projects, which were conducted in Botswana, Kenya and Uganda by the University of Washington and the Centres for Disease Control and Prevention, found that the pills reduced the risk of HIV infection by up to 63 percent.
These results come as a US pharmaceutical company has made a deal to increase access to HIV/AIDS treatment drugs in developing countries across the world.
READ MORE FROM THE WDM CONTENT NETWORK:
To read the latest edition of Healthcare Global, click here
- Drinking eight glasses of water is bad for your health
- Improper Facebook conduct could see nurses struck off
- BRICS countries pledge to lower medicine costs
Working together with the Medicines Patent Poll, pharmaceutical giant Gilead Sciences has signed a deal which will see four HIV drug treatments reproduced in a low-cost copycat format.
It is a groundbreaking deal as two of the drugs are still in clinical development and include the Quad, a much anticipated single-pill medication treatment.
The already established HIV medications of tenofovir and emtricitabine are also included in the licensing agreement.
Ellen ‘t Hoen, the Executive Director of the Pool, said: “Today marks a milestone in managing patents for public health.”
“The licence agreement with Gilead Sciences will help make medicines available at a lower cost and in easier-to-use formulations without delays.”
She added: “People in developing countries often have to wait for years before they can access new health technologies. Today's agreement changed that.”
The medicines that were used in the African trials were HIV drugs manufactured by Gilead Sciences.
As part of the studies, participants were given either an HIV drug or a placebo alternative.
However, as it emerged the drugs were so successful in reducing the infection risk, the placebo arm of the study was cut short so those participants could also benefit from the effects of the specific HIV medication.
Schneider Electric's intelligent patient room: need to know
Schneider Electric has launched a virtual showcase that features its new "intelligent patient room". What is it exactly?
Who: Schneider Electric is a multinational that develops energy and automation solutions for many different industries - including hospitality, education, defence, and healthcare. Founded in 1836, today it is a Fortune 500 company, and it currently provides technology to 40% of hospitals around the world, among them Penn Medicine, one of the top hospitals in the US where Schneider's EcoStruxure for Healthcare is deployed, an IoT solution.
What: Schneider has launched its Innovation Experience Live Healthcare Lab, an immersive experience that takes visitors through a demonstration of a hospital, including the doctor’s office, the operating room, and the intelligent patient room.
The room features a digital patient footwall - a touchscreen that creates a single reference point for patients, families and healthcare providers, by incorporating care information, entertainment and environmental controls all in one place. A separate digital patient door display has important information for healthcare staff.
All Schneider's equipment is low-voltage, and integrated so that the patient room, clinical needs and IT are all seamlessly connected, what Schneider calls a digital “system of systems.”
Why: Mike Sanders, Customer Projects & Services in Healthcare Innovation at Schneider Electric, explains: “The hospital of the future will need to put the patient experience at the forefront, using innovative and connected systems to provide superior in-hospital care experiences.”
“With the shift to remote work and business brought forth by the pandemic, we knew that we needed to invest in a new virtual experience that showcases our vision for a truly integrated healthcare experience. We believe our intelligent patient room is the solution that our healthcare partners and customers have been looking for, and we’re excited to offer a way for them to experience it no matter where they are in the world.”
Where: The virtual experience was modelled after the new innovations installed at Penn Medicine in Philadelphia, the first real-world installation of Schneider Electric’s fully integrated intelligent patient room technology. It is currently being hosted at the company’s St. Louis Innovation Hub and Innovation Executive Briefing Center (IEBC) facility.